Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: Involvement of the u-PAR/LRP plasminolytic system

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1743, Issue 3, 2005, Pages 243-253

  Michaud Levesque, Jonathan ^a   Rolland, Yannève ^a   Demeule, Michel ^a   Bertrand, Yanick ^a   Béliveau, Richard ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Cell movement; Melanotransferrin; Plasminogen; Tubulogenesis; Urokinase type plasminogen activator receptor

Indexed keywords

GLYCOSYLATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MORPHOGEN; PLASMINOGEN; RECOMBINANT PROTEIN; RECOMBINANT SOLUBLE MELANOTRANSFERRIN; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ARTICLE; CELL MATURATION; CELL MIGRATION; CELL MOTION; CELL SURFACE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME BINDING; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; MICROVASCULATURE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 17444376428     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2004.10.010     Document Type: Article

References (58)

1. J.P. Brown, R.G. Woodbury, C.E. Hart, I. Hellstrom, and K.E. Hellstrom Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues Proc. Natl. Acad. Sci. U. S. A. 78 1981 539 543
2. J.P. Brown, R.M. Hewick, I. Hellstrom, K.E. Hellstrom, R.F. Doolittle, and W.J. Dreyer Human melanoma-associated antigen p97 is structurally and functionally related to transferrin Nature 296 1982 171 173
3. T.M. Rose, G.D. Plowman, D.B. Teplow, W.J. Dreyer, K.E. Hellstrom, and J.P. Brown Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence Proc. Natl. Acad. Sci. U. S. A. 83 1986 1261 1265
4. R.G. Woodbury, J.P. Brown, S.M. Loop, K.E. Hellstrom, and I. Hellstrom Analysis of normal neoplastic human tissues for the tumor-associated protein p97 Int. J. Cancer 27 1981 145 149
5. R.G. Woodbury, J.P. Brown, M.Y. Yeh, I. Hellstrom, and K.E. Hellstrom Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms Proc. Natl. Acad. Sci. U. S. A. 77 1980 2183 2187
6. R. Sciot, R. de Vos, P. van Eyken, K. van der Steen, P. Moerman, and V.J. Desmet In situ localization of melanotransferrin (melanoma-associated antigen P97) in human liver. A light- and electron microscopic immunohistochemical study Liver 9 1989 110 119
7. R. Alemany, M.R. Vila, C. Franci, G. Egea, F.X. Real, and T.M. Thomson Glycosyl phosphatidylinositol membrane anchoring of melanotransferrin (p97): apical compartmentalization in intestinal epithelial cells J. Cell Sci. 104 Pt 4 1993 1155 1162
8. S. Rothenberger, M.R. Food, R. Gabathuler, M.L. Kennard, T. Yamada, O. Yasuhara, P.L. McGeer, and W.A. Jefferies Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium Brain Res. 712 1996 117 121
9. T. Kawamoto, H. Pan, W. Yan, H. Ishida, E. Usui, R. Oda, K. Nakamasu, M. Noshiro, Y. Kawashima-Ohya, M. Fujii, H. Shintani, Y. Okada, and Y. Kato Expression of membrane-bound transferrin-like protein p97 on the cell surface of chondrocytes Eur. J. Biochem. 256 1998 503 509
10. M.R. Food, S. Rothenberger, R. Gabathuler, I.D. Haidl, G. Reid, and W.A. Jefferies Transport and expression in human melanomas of a transferrin-like glycosylphosphatidylinositol-anchored protein J. Biol. Chem. 269 1994 3034 3040
11. E. Sekyere, M.R. Food, and D.R. Richardson A second melanotransferrin gene (MTf2) and a novel protein isoform: explanation for the membrane-bound and soluble forms of melanotransferrin? FEBS Lett. 512 2002 350 352
12. K. Kriegerbeckova, and J. Kovar Role of melanotransferrin (p97) in non-transferrin iron uptake by HeLa and K562 cells Folia Biol. (Praha) 46 2000 77 81
13. D.R. Richardson The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell Eur. J. Biochem. 267 2000 1290 1298
14. E. Sekyere, and D.R. Richardson The membrane-bound transferrin homologue melanotransferrin: roles other than iron transport? FEBS Lett. 483 2000 11 16
15. M.R. Food, E.O. Sekyere, and D.R. Richardson The soluble form of the membrane-bound transferrin homologue, melanotransferrin, inefficiently donates iron to cells via nonspecific internalization and degradation of the protein Eur. J. Biochem. 269 2002 4435 4445
16. M.L. Kennard, H. Feldman, T. Yamada, and W.A. Jefferies Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease Nat. Med. 2 1996 1230 1235
17. D.K. Kim, M.Y. Seo, S.W. Lim, S. Kim, J.W. Kim, B.J. Carroll, D.Y. Kwon, T. Kwon, and S.S. Kang Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease Neuropsychopharmacology 25 2001 84 90
18. M. Ujiie, D.L. Dickstein, and W.A. Jefferies p97 as a biomarker for Alzheimer disease Front. Biosci. 7 2002 e42 e47
19. R.R. Desrosiers, Y. Bertrand, Q.T. Nguyen, M. Demeule, R. Gabathuler, M.L. Kennard, S. Gauthier, and R. Beliveau Expression of melanotransferrin isoforms in human serum: relevance to Alzheimer's disease Biochem. J. 374 2003 463 471
20. M.S. O'Reilly, L. Holmgren, Y. Shing, C. Chen, R.A. Rosenthal, Y. Cao, M. Moses, W.S. Lane, E.H. Sage, and J. Folkman Angiostatin: a circulating endothelial cell inhibitor that suppresses angiogenesis and tumor growth Cold Spring Harbor Symp. Quant. Biol. 59 1994 471 482
21. M.S. O'Reilly, L. Holmgren, C. Chen, and J. Folkman Angiostatin induces and sustains dormancy of human primary tumors in mice Nat. Med. 2 1996 689 692
22. M. Papetti, and I.M. Herman Mechanisms of normal and tumor-derived angiogenesis Am. J. Physiol., Cell Physiol. 282 2002 C947 C970
23. D. Olson, J. Pollanen, G. Hoyer-Hansen, E. Ronne, K. Sakaguchi, T.C. Wun, E. Appella, K. Dano, and F. Blasi Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor J. Biol. Chem. 267 1992 9129 9133
24. K. Orth, T. Willnow, J. Herz, M.J. Gething, and J. Sambrook Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator J. Biol. Chem. 269 1994 21117 21122
25. M. Conese, A. Nykjaer, C.M. Petersen, O. Cremona, R. Pardi, P.A. Andreasen, J. Gliemann, E.I. Christensen, and F. Blasi Alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor J. Cell Biol. 131 1995 1609 1622
26. A. Nykjaer, M. Conese, E.I. Christensen, D. Olson, O. Cremona, J. Gliemann, and F. Blasi Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes EMBO J. 16 1997 2610 2620
27. M.M. Hussain Structural, biochemical and signaling properties of the low-density lipoprotein receptor gene family Front. Biosci. 6 2001 D417 D428
28. G. Bu, S. Williams, D.K. Strickl, and A.L. Schwartz Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator Proc. Natl. Acad. Sci. U. S. A. 89 1992 7427 7431
29. J. Herz, D.E. Clouthier, and R.E. Hammer LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation Cell 71 1992 411 421
30. B. Chazaud, S. Bonavaud, A. Plonquet, M. Pouchelet, R.K. Gherardi, and G. Barlovatz-Meimon Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility Exp. Cell Res. 258 2000 237 244
31. D.A. Waltz, R.M. Fujita, X. Yang, L. Natkin, S. Zhuo, C.J. Gerard, S. Rosenberg, and H.A. Chapman Nonproteolytic role for the urokinase receptor in cellular migration in vivo Am. J. Respir. Cell Mol. Biol. 22 2000 316 322
32. G. van der Pluijm, B. Sijmons, H. Vloedgraven, C. van der Bent, J.W. Drijfhout, J. Verheijen, P. Quax, M. Karperien, S. Papapoulos, and C. Lowik Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo Am. J. Pathol. 159 2001 971 982
33. E. Pluskota, D.A. Soloviev, and E.F. Plow Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration Blood 101 2003 1582 1590
34. R.L. Cohen, X.P. Xi, C.W. Crowley, B.K. Lucas, A.D. Levinson, and M.A. Shuman Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells Blood 78 1991 479 487
35. L.S. Reiter, E.K. Kruithof, J.F. Cajot, and B. Sordat The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells Int. J. Cancer 53 1993 444 450
36. Y. Gong, S.O. Kim, J. Felez, D.K. Grella, F.J. Castellino, and L.A. Miles Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface J. Biol. Chem. 276 2001 19078 19083
37. S. Gately, P. Twardowski, M.S. Stack, D.L. Cundiff, D. Grella, F.J. Castellino, J. Enghild, H.C. Kwaan, F. Lee, R.A. Kramer, O. Volpert, N. Bouck, and G.A. Soff The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin Proc. Natl. Acad. Sci. U. S. A. 94 1997 10868 10872
38. K.A. Hajjar, A.T. Jacovina, and J. Chacko An endothelial cell receptor for plasminogen/tissue plasminogen activator: I. Identity with annexin II J. Biol. Chem. 269 1994 21191 21197
39. K.A. Hajjar Cellular receptors in the regulation of plasmin generation Thromb. Haemost. 74 1995 294 301
40. J.M. Rakic, C. Maillard, M. Jost, K. Bajou, V. Masson, L. Devy, V. Lambert, J.M. Foidart, and A. Noel Role of plasminogen activator-plasmin system in tumor angiogenesis Cell. Mol. Life Sci. 60 2003 463 473
41. M. Demeule, Y. Bertrand, J. Michaud-Levesque, J. Jodoin, Y. Rolland, R. Gabathuler, and R. Beliveau Regulation of plasminogen activation: a role for melanotransferrin (p97) in cell migration Blood 102 2003 1723 1731
42. N. Ahmed, K. Oliva, Y. Wang, M. Quinn, and G. Rice Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells Br. J. Cancer 89 2003 374 384
43. M. Hatziapostolou, P. Katsoris, and E. Papadimitriou Different inhibitors of plasmin differentially affect angiostatin production and angiogenesis Eur. J. Pharmacol. 460 2003 1 8
44. S. Miura, M. Emoto, Y. Matsuo, T. Kawarabayashi, and K. Saku Carcinosarcoma-induced endothelial cells tube formation through KDR/Flk-1 is blocked by TNP-470 Cancer Lett. 203 2004 45 50
45. Y. Cao, R.W. Ji, D. Davidson, J. Schaller, D. Marti, S. Sohndel, S.G. McCance, M.S. O'Reilly, M. Llinas, and J. Folkman Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells J. Biol. Chem. 271 1996 29461 29467
46. G. Kassam, M. Kwon, C.S. Yoon, K.S. Graham, M.K. Young, S. Gluck, and D.M. Waisman Purification and characterization of A61. An angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors J. Biol. Chem. 276 2001 8924 8933
47. T. Tarui, M. Majumdar, L.A. Miles, W. Ruf, and Y. Takada Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin J. Biol. Chem. 277 2002 33564 33570
48. H.Y. Min, L.V. Doyle, C.R. Vitt, C.L. Zandonella, J.R. Stratton-Thomas, M.A. Shuman, and S. Rosenberg Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice Cancer Res. 56 1996 2428 2433
49. A. Stahl, and B.M. Mueller Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system Int. J. Cancer 71 1997 116 122
50. A.M. Weaver, I.M. Hussaini, A. Mazar, J. Henkin, and S.L. Gonias Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin J. Biol. Chem. 272 1997 14372 14379
51. S. Mohanam, C.L. Gladson, C.N. Rao, and J.S. Rao Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors Front. Biosci. 4 1999 D178 D187
52. D.J. Webb, D.H. Nguyen, and S.L. Gonias Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion J. Cell Sci. 113 Pt 1 2000 123 134
53. Y. Li, J.M. Knisely, W. Lu, L.M. McCormick, J. Wang, J. Henkin, A.L. Schwartz, and G. Bu Low density lipoprotein (LDL) receptor-related protein 1B impairs urokinase receptor regeneration on the cell surface and inhibits cell migration J. Biol. Chem. 277 2002 42366 42371
54. M. Demeule, J. Poirier, J. Jodoin, Y. Bertrand, R.R. Desrosiers, C. Dagenais, T. Nguyen, J. Lanthier, R. Gabathuler, M. Kennard, W.A. Jefferies, D. Karkan, S. Tsai, L. Fenart, R. Cecchelli, and R. Beliveau High transcytosis of melanotransferrin (P97) across the blood-brain barrier J. Neurochem. 83 2002 924 933
55. R.L. Klemke, S. Cai, A.L. Giannini, P.J. Gallagher, P. de Lanerolle, and D.A. Cheresh Regulation of cell motility by mitogen-activated protein kinase J. Cell Biol. 137 1997 481 492
56. D.H. Nguyen, A.D. Catling, D.J. Webb, M. Sankovic, L.A. Walker, A.V. Somlyo, M.J. Weber, and S.L. Gonias Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner J. Cell Biol. 146 1999 149 164
57. P.E. Hughes, M.W. Renshaw, M. Pfaff, J. Forsyth, V.M. Keivens, M.A. Schwartz, and M.H. Ginsberg Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway Cell 88 1997 521 530
58. H. Xie, M.A. Pallero, K. Gupta, P. Chang, M.F. Ware, W. Witke, D.J. Kwiatkowski, D.A. Lauffenburger, J.E. Murphy-Ullrich, and A. Wells EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway J. Cell Sci. 111 Pt 5 1998 615 624